Court Opinion

ID: 8406825
Source: CourtListenerOpinion
Date Created: 2022-10-31 15:00:54.428855+00
Date Added: 2024-06-11T16:47:20.511809
License: Public Domain

Case: 21-1078   Document: 94     Page: 1   Filed: 10/31/2022

           NOTE: This order is nonprecedential.

   United States Court of Appeals
       for the Federal Circuit
                 ______________________

          BIOGEN INTERNATIONAL GMBH,
                BIOGEN MA INC.,
                Plaintiffs-Appellants

                            v.

   AMNEAL PHARMACEUTICALS LLC, ALKEM
 LABORATORIES LTD., HETERO USA INC., CIPLA
    LIMITED, CIPLA USA INC., HETERO LABS
   LIMITED, HETERO LABS LIMITED UNIT-III,
      LUPIN ATLANTIS HOLDINGS SA, MSN
       LABORATORIES PRIVATE LTD., MSN
  PHARMACEUTICALS INC., PHARMATHEN S.A.,
    PRINSTON PHARMACEUTICAL INC., S&B
 PHARMA, INC., SANDOZ INC., SHILPA MEDICARE
 LIMITED, SUN PHARMACEUTICAL INDUSTRIES,
      INC., SUN PHARMA GLOBAL FZE, SUN
   PHARMACEUTICAL INDUSTRIES LIMITED,
   ZYDUS PHARMACEUTICALS (USA) INC., TWI
         PHARMACEUTICALS INC., TWI
         PHARMACEUTICALS USA, INC.,
                Defendants-Appellees

      ACCORD HEALTHCARE INC., GRAVITI
        PHARMACEUTICALS INC., GRAVITI
      PHARMACEUTICALS PVT. LTD., IMPAX
  LABORATORIES LLC, MACLEODS PHARMA USA,
    INC., MACLEODS PHARMACEUTICALS LTD.,
   SLAYBACK PHARMA LLC, SLAYBACK PHARMA
  INDIA LLP, TORRENT PHARMA INC., TORRENT
Case: 21-1078    Document: 94     Page: 2   Filed: 10/31/2022

 2                   BIOGEN INTERNATIONAL GMBH v. AMNEAL
                                    PHARMACEUTICALS LLC

        PHARMACEUTICALS LTD., WINDLAS
            HEALTHCARE PVT. LTD.,
                  Defendants

                  ______________________

 2021-1078, 2021-1084, 2021-1086, 2021-1087, 2021-1088,
 2021-1090, 2021-1091, 2021-1092, 2021-1093, 2021-1094,
 2021-1095, 2021-1096, 2021-1097, 2021-1098, 2021-1441
                ______________________

     Appeals from the United States District Court for the
 District of Delaware in Nos. 1:17-cv-00823-MN, 1:17-cv-
 00825-MN, 1:17-cv-00828-MN, 1:17-cv-00845-MN, 1:17-cv-
 00846-MN, 1:17-cv-00847-MN, 1:17-cv-00850-MN, 1:17-cv-
 00851-MN, 1:17-cv-00853-MN, 1:17-cv-00855-MN, 1:17-cv-
 00856-MN, 1:17-cv-00872-MN, 1:17-cv-00874-MN, 1:17-cv-
 00954-MN, and 1:20-cv-01159-MN, Judge Maryellen
 Noreika.
                  ______________________

                      ON MOTION
                  ______________________

                        ORDER
     Upon consideration of appellants’ unopposed motion to
 voluntarily dismiss the above-captioned consolidated ap-
 peals pursuant to Federal Rule of Appellate Procedure
 42(b) with each party to bear its own costs upon dismissal,
     IT IS ORDERED THAT:
     (1) The motion is granted. The above-captioned ap-
 peals are dismissed.
     (2) Any other pending motion is denied as moot.
Case: 21-1078   Document: 94     Page: 3      Filed: 10/31/2022

 BIOGEN INTERNATIONAL GMBH   v. AMNEAL                        3
 PHARMACEUTICALS LLC

    (3) Each side shall bear its own costs.
                                   FOR THE COURT

 October 31, 2022                  /s/ Peter R. Marksteiner
      Date                         Peter R. Marksteiner
                                   Clerk of Court

 ISSUED AS A MANDATE: October 31, 2022